This is a specific type of inherited muscle weakness that comes and goes. It's caused by a problem with the body's sodium channels and affects potassium levels. Attacks usually happen after rest and can cause weakness in the legs, arms, or trunk.
Every report comes from a Lived member, sent anonymously.
Have you tried Dichlorphenamide for Hyperkalemic Periodic Paralysis?
Hyperkalemic periodic paralysis (HyperPP) is a rare inherited muscle condition that causes sudden episodes of muscle weakness or temporary paralysis. During an attack, the arms and legs most often become weak or impossible to move, and then strength returns. Attacks typically begin in childhood, often in the morning, and usually last less than two hours, though they can happen often. "Hyperkalemic" means high blood potassium. In many people, potassium in the blood rises during an attack because weakened muscles release it, but in some it stays normal. Many people also have muscle stiffness between attacks, called myotonia, especially in the face and hands. HyperPP is one of several periodic paralyses. It is important to tell it apart from the low-potassium form, hypokalemic periodic paralysis, because potassium is part of treating that condition but makes HyperPP worse.
HyperPP is caused by changes in the SCN4A gene, which carries instructions for sodium channels in the muscles used for movement. These channels act like gates that let sodium into muscle cells so the muscle can contract. In HyperPP, the gates stay open too long, and the muscle cell becomes temporarily unable to respond to nerve signals. The condition is usually inherited in an autosomal dominant pattern, meaning a child of an affected parent has a 50% chance of inheriting it. A gene change cannot be found in a minority of people with typical symptoms. The gene change creates the vulnerability, and everyday triggers set off individual attacks. Common triggers include potassium-rich foods such as bananas and potatoes, potassium supplements, resting after exercise, fasting or going a long time without eating, cold, stress, fatigue and pregnancy. Some medicines and surgery under anesthesia can also bring on an attack.
Diagnosis starts with the pattern: repeated, brief episodes of weakness beginning early in life, often with relatives who have similar episodes. Genetic testing for SCN4A is usually the first test when a clinician suspects periodic paralysis, and finding a known disease-causing change confirms the diagnosis. Genetic testing finds a cause in roughly 60% to 70% of people who meet the clinical picture, so other evidence matters when it is negative. A blood potassium level measured during an attack is especially useful: a level above 4.5 mmol/L (the upper end of the normal range) during weakness supports HyperPP, while a low level points to the hypokalemic form. A specialized nerve and muscle study called the long exercise test, which measures how a muscle's electrical response changes after a few minutes of exercise, can also support the diagnosis. Clinicians also check for other causes of high or low potassium, such as kidney or thyroid problems.
Treatment aims to prevent attacks, shorten them when they happen and protect long-term strength. The first step is usually learning one's own triggers. Eating regular meals with frequent small carbohydrate snacks, avoiding fasting, limiting potassium-rich foods, staying warm and avoiding strenuous exercise followed by sudden rest help many people. A dietitian can help plan meals around these limits. At the start of an attack, gentle movement such as walking or shaking the arms, plus a carbohydrate snack, may help it pass. Some people use an albuterol inhaler (the same kind of rescue inhaler used for asthma), which can lower potassium in the blood; this is based on case reports and should be planned with a clinician. When attacks remain frequent, preventive medicines can help. Dichlorphenamide (Keveyis) is a carbonic anhydrase inhibitor approved by the US Food and Drug Administration for primary periodic paralysis, and in randomized trials it reduced how often attacks happened and how severe they were. Acetazolamide, a related older medicine, and thiazide diuretics such as hydrochlorothiazide, which help the kidneys remove potassium, are other options with less formal evidence. Carbonic anhydrase inhibitors commonly cause tingling in the hands and feet, fatigue, changes in taste and mild, reversible fogginess, and they raise the risk of kidney stones. Blood potassium and bicarbonate are checked during dichlorphenamide treatment, and the response is reviewed after about two months to decide whether to continue. Potassium supplements and potassium-sparing diuretics, which are sometimes used for the low-potassium form, should be avoided in HyperPP.
Attacks tend to become more frequent through childhood and early adulthood and then often ease after mid-adulthood. Between attacks, many people feel close to normal, though muscle stiffness, fatigue and low energy can affect school, work, sport and social life. Knowing personal triggers and having a plan for meals and activity can make attacks less disruptive. For children, letting the school know about the condition and what helps during an attack is useful. Over time, many people develop some weakness that does not go away between attacks. More than 80% of people with HyperPP over age 40 have some permanent weakness, and about one in three develop a slowly progressive muscle disease (myopathy). Follow-up with a neurologist familiar with muscle channel disorders helps track strength and adjust treatment. Surgery needs advance planning. Anesthesia can trigger an attack, so the surgical and anesthesia teams should know about HyperPP beforehand. They can then avoid potassium-containing IV fluids and certain muscle relaxants such as succinylcholine, prevent long fasting and keep the body warm. Pregnancy can also trigger attacks and is worth planning with the care team.
Arrange an evaluation if you or your child has repeated episodes of weakness that come and go, especially with a family history of similar episodes. Contact your care team if attacks become more frequent or longer than usual, if weakness does not fully recover between attacks, or if a preventive medicine causes troublesome side effects. Get emergency care for weakness that affects breathing or swallowing, or for weakness that comes with numbness, pain, confusion or loss of consciousness. These are not typical of HyperPP and may signal another cause, such as a stroke or a nerve disorder, that needs urgent treatment. A first-ever episode of sudden paralysis also needs urgent medical assessment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hyperkalemic Periodic Paralysis is like, what's helped you, or ask the community a question.